177 related articles for article (PubMed ID: 27610392)
1. Effect of HSV-IL12 Loaded Tumor Cell-Based Vaccination in a Mouse Model of High-Grade Neuroblastoma.
Bauer DF; Pereboeva L; Gillespie GY; Cloud GA; Elzafarany O; Langford C; Markert JM; Lamb LS
J Immunol Res; 2016; 2016():2568125. PubMed ID: 27610392
[TBL] [Abstract][Full Text] [Related]
2. Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors.
Parker JN; Gillespie GY; Love CE; Randall S; Whitley RJ; Markert JM
Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2208-13. PubMed ID: 10681459
[TBL] [Abstract][Full Text] [Related]
3. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
Sandler AD; Chihara H; Kobayashi G; Zhu X; Miller MA; Scott DL; Krieg AM
Cancer Res; 2003 Jan; 63(2):394-9. PubMed ID: 12543793
[TBL] [Abstract][Full Text] [Related]
4. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
Todo T; Martuza RL; Dallman MJ; Rabkin SD
Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154
[TBL] [Abstract][Full Text] [Related]
5. Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors.
Iwadate Y; Yamaura A; Sato Y; Sakiyama S; Tagawa M
Cancer Res; 2001 Dec; 61(24):8769-74. PubMed ID: 11751397
[TBL] [Abstract][Full Text] [Related]
6. Effective immunization against neuroblastoma using double-transduced tumor cells secreting GM-CSF and interferon-gamma.
Bausero MA; Panoskaltsis-Mortari A; Blazar BR; Katsanis E
J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):113-24. PubMed ID: 8732694
[TBL] [Abstract][Full Text] [Related]
7. Surgical excision combined with autologous whole tumor cell vaccination is an effective therapy for murine neuroblastoma.
Ohashi K; Kobayashi G; Fang S; Zhu X; Antonia SJ; Krieg AM; Sandler AD
J Pediatr Surg; 2006 Aug; 41(8):1361-8. PubMed ID: 16863838
[TBL] [Abstract][Full Text] [Related]
8. Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus.
Todo T; Rabkin SD; Sundaresan P; Wu A; Meehan KR; Herscowitz HB; Martuza RL
Hum Gene Ther; 1999 Nov; 10(17):2741-55. PubMed ID: 10584921
[TBL] [Abstract][Full Text] [Related]
9. NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine.
Alkayyal AA; Tai LH; Kennedy MA; de Souza CT; Zhang J; Lefebvre C; Sahi S; Ananth AA; Mahmoud AB; Makrigiannis AP; Cron GO; Macdonald B; Marginean EC; Stojdl DF; Bell JC; Auer RC
Cancer Immunol Res; 2017 Mar; 5(3):211-221. PubMed ID: 28159747
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor effect of the alphavirus-based virus-like particle vector expressing prostate-specific antigen in a HLA-DR transgenic mouse model of prostate cancer.
Riabov V; Tretyakova I; Alexander RB; Pushko P; Klyushnenkova EN
Vaccine; 2015 Oct; 33(41):5386-5395. PubMed ID: 26319744
[TBL] [Abstract][Full Text] [Related]
11. Triple combination of oncolytic herpes simplex virus-1 vectors armed with interleukin-12, interleukin-18, or soluble B7-1 results in enhanced antitumor efficacy.
Ino Y; Saeki Y; Fukuhara H; Todo T
Clin Cancer Res; 2006 Jan; 12(2):643-52. PubMed ID: 16428511
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for neuroblastoma using syngeneic fibroblasts transfected with IL-2 and IL-12.
Barker SE; Grosse SM; Siapati EK; Kritz A; Kinnon C; Thrasher AJ; Hart SL
Br J Cancer; 2007 Jul; 97(2):210-7. PubMed ID: 17595664
[TBL] [Abstract][Full Text] [Related]
13. Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12.
Parker JN; Meleth S; Hughes KB; Gillespie GY; Whitley RJ; Markert JM
Cancer Gene Ther; 2005 Apr; 12(4):359-68. PubMed ID: 15678154
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of IL-15 enhances anti-neuroblastoma effectivity of a tyrosine hydroxylase-directed DNA vaccination in mice.
Marx M; Zumpe M; Troschke-Meurer S; Shah D; Lode HN; Siebert N
PLoS One; 2018; 13(11):e0207320. PubMed ID: 30452438
[TBL] [Abstract][Full Text] [Related]
15. Neuroblastoma regression and immunity induced by transgenic expression of interleukin-12.
Davidoff AM; Kimbrough SA; Ng CY; Shochat SJ; Vanin EF
J Pediatr Surg; 1999 May; 34(5):902-6; discussion 906-7. PubMed ID: 10359203
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection.
Jarnagin WR; Zager JS; Klimstra D; Delman KA; Malhotra S; Ebright M; Little S; DeRubertis B; Stanziale SF; Hezel M; Federoff H; Fong Y
Cancer Gene Ther; 2003 Mar; 10(3):215-23. PubMed ID: 12637943
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease.
Srinivasan P; Wu X; Basu M; Rossi C; Sandler AD
PLoS Med; 2018 Jan; 15(1):e1002497. PubMed ID: 29377881
[TBL] [Abstract][Full Text] [Related]
18. Intravenous injection of MVA virus targets CD8+ lymphocytes to tumors to control tumor growth upon combinatorial treatment with a TLR9 agonist.
Fend L; Gatard-Scheikl T; Kintz J; Gantzer M; Schaedler E; Rittner K; Cochin S; Fournel S; Préville X
Cancer Immunol Res; 2014 Dec; 2(12):1163-74. PubMed ID: 25168392
[TBL] [Abstract][Full Text] [Related]
19. B7-1 expression decreases tumorigenicity and induces partial systemic immunity to murine neuroblastoma deficient in major histocompatibility complex and costimulatory molecules.
Katsanis E; Xu Z; Bausero MA; Dancisak BB; Gorden KB; Davis G; Gray GS; Orchard PJ; Blazar BR
Cancer Gene Ther; 1995 Mar; 2(1):39-46. PubMed ID: 7542553
[TBL] [Abstract][Full Text] [Related]
20. Serum from mice immunized in the context of Treg inhibition identifies DEK as a neuroblastoma tumor antigen.
Zheng J; Kohler ME; Chen Q; Weber J; Khan J; Johnson BD; Orentas RJ
BMC Immunol; 2007 Mar; 8():4. PubMed ID: 17397536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
